Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last €357.00 EUR
Change Today -0.50 / -0.14%
Volume 0.0
PHH2 On Other Exchanges
As of 2:09 AM 07/31/15 All times are local (Market data is delayed by at least 15 minutes).

paul hartmann ag (PHH2) Snapshot

Previous Close
Day High
Day Low
52 Week High
04/21/15 - €383.00
52 Week Low
08/11/14 - €274.50
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for PAUL HARTMANN AG (PHH2)

Related News

No related news articles were found.

paul hartmann ag (PHH2) Related Businessweek News

No Related Businessweek News Found

paul hartmann ag (PHH2) Details

Paul Hartmann AG, together with its subsidiaries, provides medical and healthcare products in the fields of wound treatment, incontinence hygiene, and infection prevention in Europe and internationally. It offers gauze and non-woven swabs, tulle dressings, hydroactive wound dressings, sponges and tamponades, conforming bandages, wound closure strips, ready-to-use procedure trays, and negative pressure wound therapy system, as well as gauze, cotton wool, and cellulose wadding products for wound treatment. The company also provides therapeutic bandages comprising compression bandages, zinc paste bandages, synthetic casting bandages and accessories, plaster of paris bandages and accessories, tubular bandages, and strapping and sports bandages; first aid products, such as adhesive wound dressings and surgical tapes; and diagnostic products comprising clinical thermometers and blood pressure monitors. In addition, it offers incontinence hygiene products, including incontinence pads, elasticated net pants and fixation belts, incontinence briefs, incontinence pants, and incontinence underpads; patient care products, and disposable products for personal hygiene; and skin care products for irritated skin. Further, the company provides operating theater products consisting of surgical procedure trays, surgical draping systems, operating theater clothing, surgical gloves, surgical absorbents, and disposable surgical instruments; patient care products, including examination gloves; and disinfectants for hands, skin, instruments, devices, and surfaces. Paul Hartmann AG provides its products and services for professional users in hospitals, doctors’ surgeries, and in homes for the elderly, as well as in home care; and for end-consumers through pharmacies and specialist medical supply stores. The company was founded in 1818 is headquartered in Heidenheim, Germany.

Founded in 1818

paul hartmann ag (PHH2) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

paul hartmann ag (PHH2) Key Developments

Paul Hartmann AG Announces Earnings Results for the Year Ended December 31, 2014; Provides Earnings Guidance for 2015; Proposes Dividend for 2014

Paul Hartmann AG announced earnings results for the year ended December 31, 2014 . For the year, the company increased global sales revenues to EUR 1,862.0 million. This is an increase of 3.8% compared to previous year's record. With EBIT of EUR 122.4 million, the company increased the prior year's results by 20.0%. In addition to positive sales performance, the increased sales of higher-margin products and increased productivity contributed to the improvement in results. The consolidated net income was EUR 78.3 million, an increase of 25.4% compared to the previous year. Net debt of EUR 59.0 million at the end of 2013 was completely eliminated. At the Annual General Meeting, the Management Board and the Supervisory Board will propose a dividend increase from EUR 5.70 to EUR 6.50 per share. With this proposal for the appropriation of net income, the dividend yield is 2.0% when related to the 2014 year-end rate. For fiscal 2015, the company expects that the programs and measures will have a positive effect on sales and earnings. Considering all relevant factors, the company is cautiously optimistic for fiscal year 2015 that the company will have moderate increase in sales revenues and EBIT.

Paul Hartmann AG, 2014 Earnings Call, Mar 26, 2015

Paul Hartmann AG, 2014 Earnings Call, Mar 26, 2015

Hartmann Group Opens Medical Innovation Center at Heidenheim, Southern Germany

Hartmann Group has opened the medical innovation center at its corporate headquarters in Heidenheim, southern Germany. With the Medical Innovation Center, Hartmann provides the manufacturing capacity needed to drive continued growth in the future even more in two principal business segments of the Group. In the Medical Innovation Center, products are manufactured under clean room conditions. And lean manufacturing and logistics ensure a smooth flow of materials.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PHH2:GR €357.00 EUR -0.50

PHH2 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Advanced Drainage Systems Inc $27.83 USD -0.07
De' Longhi €22.21 EUR -1.05
Halyard Health Inc $40.74 USD +0.05
Helen of Troy Ltd $87.78 USD +0.09
Hill-Rom Holdings Inc $56.03 USD +0.66
View Industry Companies

Industry Analysis


Industry Average

Valuation PHH2 Industry Range
Price/Earnings 10.1x
Price/Sales 0.4x
Price/Book 1.1x
Price/Cash Flow 5.8x
TEV/Sales 0.3x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PAUL HARTMANN AG, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at